目的以对一例弥漫性泛细支气管炎病人诊疗的全过程参与和药学监护为例,说明临床药师需要参与对患者完整的医疗过程,不断地了解相关疾病的发生发展机制及相关诊治指南,从而拓展自身更为宽泛的用药思路,以便为用药提供良好的药学支持,并为临床医生提供可靠的药学信息服务。方法阐述临床对弥漫性泛细支气管炎的定义、临床诊断该病的诊断指标和具体的治疗方案。同时,结合我院收治的弥漫性泛细支气管炎患者的病例资料、诊治经过及治疗方案中相关药物的作用机制及使用剂量和临床药师在其中发挥的作用,对弥漫性泛细支气管炎患者的药学监护进行阐述。结果弥漫性泛细支气管炎是一种弥漫存在于两肺的呼吸性细支气管的气道慢性炎症性疾病,且在临床上易与其他慢性气道疾病混淆。而目前我国尚无诊断标准,主要还是参考他国诊断标准。对于治疗方案的选择还要根据患者的病例资料分析情况进行合理选择。结论临床药师在工作中需紧密联系病例的实际情况,熟悉医生的诊疗思路及相关疾病的发生发展机制,治疗进展,诊治指南,为临床提供更为可靠的药学知识及用药思路,更好地指导临床用药方案的制定。 Objective To take a case of diffuse panbronchiolitis treatment and patient care as an example of the whole process, indicating that the need for clinical pharmacists to participate in the patient’s complete medical process, and continue to understand the pathogenesis and development of related diseases and related guidelines for treatment, so as to expand Its own broader drug treatment thinking in order to provide good pharmaceutical support for medication, and provide clinicians with reliable pharmacy information services. Methods The clinical definition of diffuse panbronchiolitis was elaborated. The diagnostic criteria and the specific treatment plan of the disease were clinically diagnosed. At the same time, combined with our hospital for patients with diffuse panbronchiolitis case information, diagnosis and treatment through the treatment of drugs and the mechanism of action and the use of dose and clinical pharmacists in which the role of diffuse bronchiolitis patients Pharmacological care to elaborate. Results Diffuse panbronchiolitis is a chronic airway inflammation that is common in respiratory bronchioles present in both lungs and is clinically confused with other chronic airway diseases. At present, there is no diagnostic criteria in our country, mainly referring to the diagnostic criteria of other countries. The choice of treatment options should also be based on the patient’s case analysis of the situation to make a reasonable choice. Conclusion Clinical pharmacists should be closely linked with the actual situation of the case at work, be familiar with the doctor’s treatment ideas and related diseases, development mechanism, treatment progress, diagnosis and treatment guidelines, to provide more reliable pharmacy knowledge and medication for clinical guidance and better guidance Development of clinical medication program.